Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Hinge Health posted $235M in Q3 revenue — a 52% jump — as its AI-powered virtual care platform expands from musculoskeletal into migraine and gastrointestinal care. The company acquired GI startup Cylinder Health for $105M and is eyeing further hardware acquisitions. With 88% of its target market still untapped, Hinge is betting on a multi-condition platform to dominate digital health.
Hinge Health is growing fast — and branching out. The digital health company, best known for its AI-powered musculoskeletal (MSK) care platform, reported $235M in Q3 2026 revenue, a 52% year-over-year jump that beat its own guidance. Its core MSK business remains the dominant revenue driver, but the company is actively building a multi-condition platform, expanding into migraine and gastrointestinal (GI) care. CEO Daniel Perez framed the expansion as a natural extension of existing employer and health plan relationships rather than a from-scratch pivot.
Early results from the migraine program are promising — a 23% reduction in monthly migraine days and a 28% drop in migraine duration — while the GI program, built on the $105M acquisition of Cylinder Health, is targeting full integration by summer 2027. Perez also flagged hardware acquisitions as a strategic priority, arguing that automating care delivery requires more than software alone.
By the Numbers:
Why it matters: As employers and health plans grapple with rising costs — especially around GLP-1-related GI side effects — an integrated digital platform covering MSK, migraine, and GI care in one app could reshape how chronic condition management is delivered and purchased at scale.
